Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4875768
Max Phase: Preclinical
Molecular Formula: C35H46N6O6
Molecular Weight: 646.79
Molecule Type: Unknown
Associated Items:
ID: ALA4875768
Max Phase: Preclinical
Molecular Formula: C35H46N6O6
Molecular Weight: 646.79
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CN1CCCNC(=O)CC(C)(C)CC(=O)NCCCN(C)CCCN2C(=O)c3ccc4c5c(ccc(c35)C2=O)C(=O)N(CCC1)C4=O
Standard InChI: InChI=1S/C35H46N6O6/c1-35(2)21-27(42)36-13-5-15-38(3)17-7-19-40-31(44)23-9-11-25-30-26(12-10-24(29(23)30)32(40)45)34(47)41(33(25)46)20-8-18-39(4)16-6-14-37-28(43)22-35/h9-12H,5-8,13-22H2,1-4H3,(H,36,42)(H,37,43)
Standard InChI Key: CBRUAOXTSBFLLQ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 646.79 | Molecular Weight (Monoisotopic): 646.3479 | AlogP: 2.51 | #Rotatable Bonds: 0 |
Polar Surface Area: 139.44 | Molecular Species: BASE | HBA: 8 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 12 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: 9.61 | CX LogP: 0.25 | CX LogD: -3.56 |
Aromatic Rings: 2 | Heavy Atoms: 47 | QED Weighted: 0.42 | Np Likeness Score: -0.08 |
1. Fukuda H, Sato S, Zou T, Higashi S, Takahashi O, Habu M, Sasaguri M, Tominaga K, Takenaka S, Takeuchi H.. (2021) Substituent effects of cyclic naphthalene diimide on G-quadruplex binding and the inhibition of cancer cell growth., 50 [PMID:34400300] [10.1016/j.bmcl.2021.128323] |
Source(1):